Literature DB >> 35641221

Blurring the Lines of Design: Prospective Observational Cohorts and Pragmatic Clinical Trials Characterizing Treatment Effects in Routine Cancer Care.

Donna R Rivera1, Erin Larkins2, Paul G Kluetz1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35641221      PMCID： PMC8895745          DOI： 10.1093/oncolo/oyab071

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159            Impact factor:   5.837


× No keyword cloud information.
  8 in total

1.  Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.

Authors:  Marc L Berger; Muhammad Mamdani; David Atkins; Michael L Johnson
Journal:  Value Health       Date:  2009-09-29       Impact factor: 5.725

2.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.

Authors:  Joseph M Unger; Elise Cook; Eric Tai; Archie Bleyer
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

3.  Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer.

Authors:  G M Blumenthal; Y Gong; K Kehl; P Mishra-Kalyani; K B Goldberg; S Khozin; P G Kluetz; G R Oxnard; R Pazdur
Journal:  Ann Oncol       Date:  2019-05-01       Impact factor: 32.976

Review 4.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

5.  The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.

Authors:  Eric I Benchimol; Liam Smeeth; Astrid Guttmann; Katie Harron; David Moher; Irene Petersen; Henrik T Sørensen; Erik von Elm; Sinéad M Langan
Journal:  PLoS Med       Date:  2015-10-06       Impact factor: 11.069

Review 6.  Venous thromboembolism and lung cancer: a review.

Authors:  Carolina Vitale; Maria D'Amato; Paolo Calabrò; Anna Agnese Stanziola; Mauro Mormile; Antonio Molino
Journal:  Multidiscip Respir Med       Date:  2015-09-15

7.  Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Authors:  Shirley V Wang; Sebastian Schneeweiss; Marc L Berger; Jeffrey Brown; Frank de Vries; Ian Douglas; Joshua J Gagne; Rosa Gini; Olaf Klungel; C Daniel Mullins; Michael D Nguyen; Jeremy A Rassen; Liam Smeeth; Miriam Sturkenboom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-09       Impact factor: 2.890

8.  "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.

Authors:  Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.